Georgi Domuschiev Net Worth: How to Verify the Estimate

As of May 2026, Georgi Domuschiev's net worth is estimated at approximately $2.9 billion, making him one of the two richest people in Bulgaria according to Forbes' 2026 World's Billionaires list. That figure comes primarily from his co-ownership (alongside his brother Kiril) of Advance Properties, the Bulgarian investment conglomerate whose crown jewel is Huvepharma, described by Forbes as the world's sixth-largest livestock health company. This is the Georgi Petrov Domuschiev you're looking for when you search that name in a wealth context. If you are also comparing other influencer-style wealth claims, you may want to check georgy kavkaz net worth as a related benchmark.

Who Georgi Domuschiev is and why the number is so large

Georgi Petrov Domuschiev (born August 1972, Bulgarian nationality) is a Sofia-based entrepreneur and co-founder of Advance Properties OOD, an investment holding company with stakes in over 100 organizations. He built his fortune alongside his brother Kiril, starting from scratch in the 1990s selling shoe products before pivoting aggressively into privatized state-owned companies during Bulgaria's post-communist transition. That regional context is important: the Domuschiev brothers are a textbook example of Eastern European entrepreneurs who captured enormous value by identifying underpriced state assets and building global-scale businesses around them.

Today his public-facing roles include Chairman of the Board of Directors of Advance Green Energy, a position confirmed in a 2026 Axpo Greece press release, and he holds documented significant control (more than 25% but not more than 50% of shares and voting rights) in Huvepharma Limited, per UK Companies House records. His wealth is not theoretical. It is anchored in a real, revenue-generating pharmaceutical business with factories in four countries including the United States, plus a media and real estate portfolio that has already been partially monetized.

Disambiguation: which Georgi Domuschiev does this cover?

There is essentially one prominent Georgi Domuschiev in global financial databases, and it is this individual. The Forbes profile, the Huvepharma prospectus filed on Euronext, UK Companies House PSC records, and Advance Properties' own website all point to the same person: Georgi Petrov Domuschiev, co-founder of Advance Properties with his brother Kiril Petrov Domuschiev. If you encounter a "Georgi Domuschiev" in any other business or professional context, verify whether the full patronymic "Petrov" appears, cross-check the nationality (Bulgarian) and date of birth (August 1972), and confirm the connection to Huvepharma or Advance Properties before treating it as the same person. Conflation risk is low because the name is uncommon outside Bulgarian circles, but it is worth confirming when sourcing.

Why net worth estimates vary depending on where you look

Even credible outlets show slightly different numbers depending on when they pulled the data and how they model private company valuations. Forbes' profile page showed a real-time figure of $2.9 billion as of April 15, 2026, with a "Last Updated" date of March 10, 2026, meaning the static profile was refreshed in March but the real-time tracker recalculates more frequently. Because Georgi Domuschiev's net worth changes with updated valuations, you can also look up Vlada Bortnik's net worth for a comparable wealth snapshot Vlada Bortnik net worth. A separate aggregator, Grizzly Bulls Billionaire Index, showed $2.88 billion as of March 8, 2026. Goodreturns reported $2.93 billion for 2025 and noted year-over-year growth. Bloomberg's methodology, by contrast, updates its Billionaires Index daily after market close, which means Bloomberg and Forbes can show different figures even on the same calendar day for the same individual.

The underlying reason for these gaps is that Huvepharma is not a fully public company with a live stock price. Estimators must use comparable company multiples, disclosed revenue figures, or prospectus-era valuations to back-calculate what the Domuschiev brothers' stakes are worth at any given moment. Currency conversion timing also matters: Huvepharma operates in Bulgarian lev, euros, and US dollars, and FX shifts between those affect any USD-denominated net worth figure. None of these estimates should be read as an exact account balance. They are informed models.

Public records and credible data points you can actually check

This is where the research gets practical. If you want to anchor your understanding of Domuschiev's wealth in primary sources rather than secondary aggregators, here is what is genuinely accessible:

• UK Companies House (GOV.UK): Search "HUVEPHARMA LIMITED" and look at the Persons with Significant Control (PSC) register. Georgi Domuschiev appears there with confirmed ownership of more than 25% but not more than 50% of shares and voting rights, notified January 15, 2021. This is a government filing, not a media estimate.
• Euronext prospectus: A 2021 Huvepharma prospectus filed in connection with a proposed listing process names Kiril Petrov Domuschiev and Georgi Petrov Domuschiev individually as the selling shareholders, with explicit stake breakdowns. This document is a legal disclosure, the highest quality ownership signal available.
• Business Wire / Fierce Pharma: A documented transaction confirmed that TRG (The Rohatyn Group) completed the sale of its 36.6% shareholding in Huvepharma AD to Advance Properties OOD, described as "a company controlled by the Domuschiev family." This is a transaction-level record, not an estimate.
• Advance Properties official website: Lists Georgi Domuschiev as co-founder and board member, describes the holding company as controlling stakes in over 100 organizations, and names Huvepharma, Nova Broadcasting Group, and PFC Ludogorets (the football club) as portfolio assets.
• Axpo Greece press release (2026): Identifies Georgi Domuschiev as Chairman of Advance Green Energy, confirming current operational roles beyond Huvepharma.
• Forbes World's Billionaires 2026: Lists him at $2.9 billion, tied as Bulgaria's richest person, with source of wealth described as "Animal health, investments."

The net worth range and how it's calculated

The most credible range for Georgi Domuschiev's net worth as of May 2026 is $2.85 billion to $2.95 billion, with the Forbes figure of $2.9 billion being the most widely cited single point estimate. Here is how that number is built:

Because Huvepharma is described as the world's sixth-largest livestock health company with manufacturing in four countries, estimators typically apply industry revenue multiples (enterprise value to EBITDA or revenue) to publicly disclosed or estimated financials, then apply Domuschiev's approximate ownership fraction from the PSC register to get his personal share. The Nova TV exit at $340 million in January 2021 is a concrete realized liquidity event that also feeds into the brothers' balance sheets. Forbes' methodology additionally notes that the brothers tend to invest 30 to 50 percent of capital directly and finance the remainder through bank loans, meaning leverage amplifies both upside and risk in these estimates.

How the wealth was built: a timeline

1. 1990s: Georgi and Kiril Domuschiev start out selling shoe products in Bulgaria, a common entrepreneurial entry point in post-communist Eastern Europe where consumer goods were scarce and margins were wide.
2. 2000: The brothers acquire a 54% stake in Biovet, a partially state-owned animal health firm, entering the livestock pharmaceutical sector. This is the foundational investment that eventually becomes Huvepharma.
3. 2003: Advance Properties OOD is formally established in Sofia as the brothers' investment holding vehicle, consolidating growing stakes across multiple sectors.
4. Mid-2000s to 2010s: Huvepharma expands internationally, building factories in multiple countries and acquiring global distribution. The Domuschiev brothers also accumulate media and real estate holdings through Advance Properties.
5. 2019 (February): Advance Properties acquires Nova TV (Nova Broadcasting Group), Bulgaria's largest commercial television network, adding a high-profile media asset to the portfolio.
6. 2021 (January): The brothers sell Nova TV for $340 million, a major liquidity event that crystallizes significant realized gains and elevates their measurable net worth.
7. 2021: TRG (The Rohatyn Group) completes the sale of its 36.6% stake in Huvepharma AD to Advance Properties OOD, consolidating Domuschiev family control over the pharmaceutical business.
8. 2021: Georgi Domuschiev is registered as a Person with Significant Control on UK Companies House for Huvepharma Limited, creating an auditable public record.
9. 2026: Forbes lists Georgi Domuschiev at $2.9 billion on its World's Billionaires list. He is also active as Chairman of Advance Green Energy, signaling ongoing expansion into renewable energy.

Key affiliations and relationships that shape the wealth picture

The most important relationship in Georgi Domuschiev's financial profile is with his brother Kiril Petrov Domuschiev. The two built and own Advance Properties jointly, and virtually every major transaction, from the Biovet acquisition to the Nova TV sale, involved both brothers acting together. Kiril is publicly listed as President of Huvepharma and holds equivalent governance roles. Any valuation of Georgi's stake has to account for the fact that ownership is split, and individual net worth estimates reflect each brother's portion separately, even though the underlying assets are jointly controlled.

Beyond the family structure, Advance Properties' relationship with international lenders is relevant. The brothers' reported strategy of financing 50 to 70 percent of acquisitions through bank debt means their equity net worth is gross of significant liabilities. Estimators who do not account for leverage may overstate the net figure. The Rohatyn Group's exit from Huvepharma in 2021 also matters because it removed a major institutional co-investor, consolidating family control but also meaning the Domuschiev brothers absorbed the entire equity risk of the business going forward.

The Confederation of Employers and Industrialists in Bulgaria (KRIB) includes Kiril Domuschiev in management and board roles, which reflects the brothers' broader influence in Bulgarian industrial and regulatory networks. This is relevant to wealth assessment because embedded institutional relationships in post-Soviet economies often create non-financial advantages (access to privatizations, regulatory clarity, financing terms) that translate into financial upside over time.

PFC Ludogorets, the Bulgarian football club owned through Advance Properties, also appears in the portfolio. Sports club ownership rarely adds material net worth directly, but it signals the breadth of the holding structure and the family's domestic profile. Researchers tracking other Bulgarian or Eastern European wealth profiles, such as those covering figures like George Papazov, will recognize this pattern of combining industrial assets with media and sports holdings as a common accumulation strategy in the region. If you are also searching for George Papazov net worth, you can use the same primary-source checking approach described for Domuschiev’s estimate.

How to verify the estimate and catch misinformation

If you want to pressure-test any net worth figure you find for Georgi Domuschiev, here is a practical checklist:

1. Check the date on the estimate. Forbes shows both a static "Last Updated" date and a real-time tracker date. A figure labeled "2024" or pulled from a cached page may be a year or more out of date, especially given the Nova TV exit and Huvepharma stake consolidation both happened in 2021.
2. Confirm the methodology. Does the source explain how it valued Huvepharma? If it just quotes Forbes without explaining the underlying model, it is a secondary aggregator, not an independent estimate. Secondary aggregators are fine for ballpark figures but should not be treated as independent confirmation.
3. Cross-reference the PSC filing. The UK Companies House PSC record for Huvepharma Limited is a primary government document. If a source claims Domuschiev owns a dramatically different percentage of Huvepharma than the "more than 25%, not more than 50%" range in that filing, ask for the supporting evidence.
4. Watch for conflation errors. Some aggregator pages confuse Georgi and Kiril Domuschiev's individual figures, or add their combined wealth together and attribute it to one person. The Forbes profiles for each brother are separate and show the individual estimate, not a combined family figure.
5. Look for liability disclosures. Net worth estimates are almost always gross asset values minus obvious known debts, but private leverage (bank loans used for acquisitions) is rarely fully disclosed. A $2.9 billion gross figure could be materially lower on a fully net basis if undisclosed debt is significant.
6. Check for recent asset sales or write-downs. A large realized gain (like the Nova TV sale) or a write-down in Huvepharma's valuation would shift the number meaningfully. Monitor Huvepharma's public communications and any Euronext filings for updated financials.
7. Be skeptical of round numbers with no methodology note. A site that says "Georgi Domuschiev net worth: $3 billion" with no source citation is almost certainly recycling Forbes' figure without independent analysis.

The bottom line is that the $2.9 billion figure is the most credibly sourced estimate available as of May 2026, grounded in Forbes' real-time methodology and consistent with ownership signals from government filings and a legal prospectus. These estimates also lead many readers to search for George Kikvadze net worth for comparison and context. It should be read as a model output based on best available data, not as a verified bank balance. That is true of virtually every private-company billionaire profile, not just Domuschiev's, and understanding that distinction is what separates an informed reader from one who takes any net worth headline at face value.